Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $589,572 - $654,627
9,254 New
9,254 $591,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $1.01 Million - $1.18 Million
-17,028 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $5.86 Million - $6.38 Million
-94,643 Reduced 84.75%
17,028 $1.14 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $3.82 Million - $4.3 Million
64,411 Added 136.29%
111,671 $7.05 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.95 Million - $2.22 Million
33,857 Added 252.61%
47,260 $2.93 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $21.2 Million - $30.8 Million
-456,281 Reduced 97.15%
13,403 $747,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $19.2 Million - $22.9 Million
425,046 Added 952.21%
469,684 $0
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $806,782 - $1.05 Million
16,546 Added 58.9%
44,638 $2.32 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $2.77 Million - $3.12 Million
-50,101 Reduced 64.07%
28,092 $0
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $1.8 Million - $2.07 Million
30,006 Added 62.27%
78,193 $0
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $481,797 - $525,283
-8,038 Reduced 14.3%
48,187 $0
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $3.11 Million - $3.58 Million
56,225
56,225 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.